Health Canada Proposes New Guidance to Streamline Drug Approvals

Health Canada has released draft guidance for a new Ministerial Reliance Order, effective July 15, 2026, aimed at accelerating access to medicines for Canadians. This initiative allows the agency to utilize decisions and documents from specific foreign regulatory bodies during its drug review process. The goal is to reduce redundant work while upholding Canada's high standards for safety, efficacy, and quality, initially focusing on pediatric and veterinary drugs.